What are the guidelines for para-aortic contouring in radiation therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Para-Aortic Contouring Guidelines for Radiation Therapy

For testicular cancer, the NCCN guidelines recommend contouring the aorta and inferior vena cava with a 1.2-1.9 cm margin to create the clinical target volume (CTV), followed by a uniform 0.5 cm expansion to create the planning target volume (PTV), with superior border at T11 and inferior border at L5. 1

Testicular Cancer: Standard Para-Aortic Strip Fields

Cranio-Caudal Borders

  • Superior border: Bottom of vertebral body T11 1, 2
  • Inferior border: Inferior border of vertebral body L5 1

Lateral Border Definition: Two Approaches

Conventional Approach:

  • Para-aortic strip fields approximately 10 cm wide, encompassing the tips of the transverse processes of the para-aortic vertebrae 1
  • Small renal blocks may be added at T12 level for patients with medially positioned kidneys 1

3D-CRT Vascular-Based Approach (Preferred):

  • Contour the aorta and inferior vena cava on non-contrast CT planning scan 1
  • Apply 1.2-1.9 cm margin on these vascular structures to create the CTV, which includes para-aortic, paracaval, interaortocaval, and preaortic nodes 1, 2
  • Expand CTV uniformly by 0.5 cm in all directions to create the PTV, accounting for setup errors 1, 2
  • Add 0.7 cm margin from PTV to block edge to account for beam penumbra 1

Renal Dose Constraints

  • Two kidneys: Right and left kidney D50% should be ≤8 Gy (no more than 50% of each kidney receives ≥8 Gy) 1
  • Single kidney: Kidney D15% should be ≤20 Gy (no more than 15% of kidney volume receives ≥20 Gy) 1

Cervical Cancer: Extended-Field Para-Aortic Contouring

Indications and Superior Extent

  • Extended-field radiation indicated for documented common iliac and/or para-aortic nodal involvement 1
  • Superior border: At least to the level of renal vessels, or more cephalad as directed by involved nodal distribution 1
  • For microscopic disease, contouring should extend up to renal vessels rather than fixed bony landmarks 3
  • Consider retrocrural lymph nodes if nodal involvement extends to renal vessels (38% of such patients have retrocrural involvement) 3

Lateral Margins: Asymmetric Expansion

Based on validated cervical cancer data, the recommended CTV expansion is: 4

  • From aorta: 10 mm circumferentially, except 15 mm laterally 4
  • From IVC: 8 mm anteromedially and 6 mm posterolaterally 4
  • This approach covers 97% of pathological para-aortic nodes in validation studies 4

Anatomic Distribution Considerations

  • Left lateral para-aortic region: Contains 59% of positive nodes 3
  • Aortocaval region: Contains 35% of positive nodes 3
  • Right paracaval region: Contains only 8% of positive nodes 3
  • Nearly all patients with right paracaval involvement also have left para-aortic involvement 3
  • Critical pitfall: Fixed circumferential margins around vessels are inadequate; asymmetric expansion is necessary 3, 4

Dose Recommendations

  • Microscopic disease: 45 Gy in conventional fractionation 1
  • Gross unresected adenopathy: Additional 10-15 Gy highly conformal boost may be considered 1
  • Treatment must not exceed bowel, spinal cord, or renal tolerances 1

General Technical Principles

Treatment Planning Requirements

  • CT-based planning with conformal blocking is standard of care 1
  • Non-contrast CT simulation should be performed 1
  • Slice thickness of 2-3 mm recommended for accurate delineation 2
  • PET imaging useful to define nodal volume coverage in patients not surgically staged 1

IMRT Considerations

  • IMRT may be helpful for minimizing dose to bowel and critical structures, particularly in para-aortic treatments 1
  • Requires very careful attention to target definitions, organ motion, soft tissue deformation, and rigorous quality assurance 1
  • Not recommended for testicular cancer due to concerns about secondary malignancies in kidneys, liver, or bowel 1

Motion Management

  • For thoracic and upper abdominal targets, 4D-CT scanning strongly preferred to account for respiratory motion 2
  • Internal target volume (ITV) approach can be used when accounting for respiratory motion 2

Common Pitfalls to Avoid

  • Do not use fixed circumferential margins around vessels for gynecologic malignancies—this misses common nodal locations 3, 4
  • Do not rely solely on bony landmarks for superior extent—use renal vessels as anatomic reference 3
  • Do not ignore interclinician variation—contouring variation can result in dose differences ranging from -289% to 56% for mean OAR dose 5
  • Do not manually adjust PTV—it accounts for setup errors and breathing motion 2, 6
  • Ensure adequate coverage of left para-aortic and aortocaval spaces, as these are most common locations 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Radiotherapy Planning Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018

Research

Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.

International journal of radiation oncology, biology, physics, 2012

Guideline

Margins for CTV and PTV from GTV for SBRT to Paraortic Lymph Nodes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.